Sutton Wealth Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
NAM
CCP
NL
Sutton Wealth Advisors's SBIO Position: Q2 2020 in Review
Sutton Wealth Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2020, closing a stake of 100 shares — an estimated $3.17K sold.
Sutton Wealth Advisors first reported a position in SBIO in Q1 2019 and held it in 5 quarters. The position peaked at $4.23K in Q4 2019. 53 funds tracked by Wall St. Rank hold SBIO as of Q2 2020.
- Sutton Wealth Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2020 after selling out during the quarter.
- Sutton Wealth Advisors sold 100 ALPS Medical Breakthroughs ETF shares in Q2 2020, an estimated $3.17K.
- Sutton Wealth Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q1 2019 and held it in 5 quarters.
- Sutton Wealth Advisors's ALPS Medical Breakthroughs ETF position peaked at $4.23K in Q4 2019.
- 53 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2020.
Based on Sutton Wealth Advisors's 13F filing for Q2 2020, filed 7 Nov 2023.